Form 4/A for GMED GLOBUS MEDICAL INC
Accepted 2023-02-06 00:00:00 ET · period of report 2021-08-19 · accession 0001209191-23-007310 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-02-06 | 2021-08-19 | GMED | Pfeil Keith W | SVP, CFO | M - OptEx | $49.65 | +833 | 833 | New | +$41.4K |
| DA | 2023-02-06 | 2021-08-19 | GMED | Pfeil Keith W | SVP, CFO | S - Sale+OE | $76.13 | -833 | 0 | -100% | -$63.4K |
| DMA | 2023-02-06 | 2021-08-19 | GMED | Pfeil Keith W | SVP, CFO | M - OptEx | $0.00 | -833 | 24.2K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-08-19 | M | A | 833 | $49.65 | 833 | D | — | — | (F1) The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65. |
| 2 | Common | Class A Common Stock | 2021-08-19 | S | D | 833 | $76.13 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2021-08-19 | M | D | 833 | $0.00 | 20,000 | D | $49.65 · — to 2029-09-03 | 833 Class A Common Stock | (F4) The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019. (F1) The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65. (F3) These options were granted on September 3, 2019 and are fully vested. |
| 4 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2021-08-19 | M | D | 0 | $0.00 | 24,167 | D | $53.27 · — to 2030-01-22 | 0 Class A Common Stock | (F4) The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019. (F5) These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |